The Vacthera Team was present and met with potential investors and strategic partners.
Vacthera was selected as one of only ten European biotech start ups to present at this year’s spin off panel at the annual BioVaria on May 22nd. BioVaria aims to connect promissing new projects with established industry players and is one of the leading events of its kind in Europe. Hosted by severeal European research promotion agencies and world leading leading German reseach organizations such as the Max Planck Gesellschaft or the Helmholtz Gemeinschaft. Additional funding is provided by the Government of the Free State of Bavaria.
To learn more go to: https://www.biovaria.org/programme/spin-offs/
On April 27th Vacthera was selected the winner of the biannual Best of Biotech competition hosted by the Austria Wirtsschaftsservice GmbH (aws), the public SME promotion agency. A jury of well regarded experts considered Vacthera to be a very promissing early stage biotech company with a destinctive approach to therapeutic areas with a high medical need. Read more on the original aws press release: http://www.bestofbiotech.at/Content.Node/winners/5445.en1.php
On March 2nd Vacthera was selected to participate in the Spring 2017 class of the inits start up camp. Inits is a world leading incubation program targeted on startups with an acadmic background. Besides a financial contribution intis offers valuable insights and training to early stage entrepreneurs with science based products and services. In a three months lasting course skills in business modeling, marketing or finance as well as story telling and presentation and pitching are sharpend and refined. Learn more here: www.inits.at
In Fall 2016 Vacthera participated as the only European project in the Commercializing Science Course at the Harvard Buisness School in Boston, Mass. This course is taught by Prof. Vicki Sato a preeminent personality in both and academia as well the biotech industry in combination with Prof. Gary Pisano. Besides being a professor for management Prof. Sato holds several board seats at big pharma as well as medium sized and up start biotech companies.
In this course MBA candidates and Postdocs from the Harvard Medical School and the MIT learn the necessary skills to successfully start their own biotech ventures. Vacthera was selected as a model case in a competitive multi stage selection process.
The HBS team helped Vacthera to sharpen its business model and better understand the dynamics of its target markets, both in cancer and vaccines.
See below Vacthera’s HBS team plus Nobel Prize winner Dr. Walter Gilbert.